155 related articles for article (PubMed ID: 35560362)
1. Implementation of TG-218 for patient-specific quality assurance tolerance and action limits determination: Gamma passing rate evaluation using 3DVH software.
Stasinou D; Patatoukas G; Kollaros N; Diamantopoulos S; Kypraiou E; Kougioumtzopoulou A; Kouloulias V; Efstathopoulos E; Platoni K
Med Phys; 2022 Jul; 49(7):4322-4334. PubMed ID: 35560362
[TBL] [Abstract][Full Text] [Related]
2. Correlation between gamma index passing rate and clinical dosimetric difference for pre-treatment 2D and 3D volumetric modulated arc therapy dosimetric verification.
Jin X; Yan H; Han C; Zhou Y; Yi J; Xie C
Br J Radiol; 2015 Mar; 88(1047):20140577. PubMed ID: 25494412
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram.
Stasi M; Bresciani S; Miranti A; Maggio A; Sapino V; Gabriele P
Med Phys; 2012 Dec; 39(12):7626-34. PubMed ID: 23231310
[TBL] [Abstract][Full Text] [Related]
4. Comparison of DVH-based plan verification methods for VMAT: ArcCHECK-3DVH system and dynalog-based dose reconstruction.
Saito M; Kadoya N; Sato K; Ito K; Dobashi S; Takeda K; Onishi H; Jingu K
J Appl Clin Med Phys; 2017 Jul; 18(4):206-214. PubMed ID: 28649722
[TBL] [Abstract][Full Text] [Related]
5. Initial experience of ArcCHECK and 3DVH software for RapidArc treatment plan verification.
Infusino E; Mameli A; Conti R; Gaudino D; Stimato G; Bellesi L; D'Angelillo RM; Ramella S; Benassi M; Trodella L
Med Dosim; 2014; 39(3):276-81. PubMed ID: 25088815
[TBL] [Abstract][Full Text] [Related]
6. VMAT QA: measurement-guided 4D dose reconstruction on a patient.
Nelms BE; Opp D; Robinson J; Wolf TK; Zhang G; Moros E; Feygelman V
Med Phys; 2012 Jul; 39(7):4228-38. PubMed ID: 22830756
[TBL] [Abstract][Full Text] [Related]
7. Development of a quasi-3D dosimeter using radiochromic plastic for patient-specific quality assurance.
Cho JD; Jin H; Jung S; Son J; Choi CH; Park JM; Kim JS; Kim JI
Med Phys; 2023 Oct; 50(10):6624-6636. PubMed ID: 37408321
[TBL] [Abstract][Full Text] [Related]
8. Evaluating AAPM-TG-218 recommendations: Gamma index tolerance and action limits in IMRT and VMAT quality assurance using SunCHECK.
Deng J; Liu S; Huang Y; Li X; Wu X
J Appl Clin Med Phys; 2024 Jan; ():e14277. PubMed ID: 38243604
[TBL] [Abstract][Full Text] [Related]
9. Individual volume-based 3D gamma indices for pretreatment VMAT QA.
Yi J; Han C; Zheng X; Zhou Y; Deng Z; Xie C; Jin X; Jin F
J Appl Clin Med Phys; 2017 May; 18(3):28-36. PubMed ID: 28318101
[TBL] [Abstract][Full Text] [Related]
10. Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis.
Sun WZ; Zhang DD; Peng YL; Chen L; Kang DH; Wang B; Deng XW
Radiat Oncol; 2018 Mar; 13(1):42. PubMed ID: 29544512
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of volumetric modulated arc therapy patient specific QA results to multileaf collimator errors and correlation to dose volume histogram based metrics.
Coleman L; Skourou C
Med Phys; 2013 Nov; 40(11):111715. PubMed ID: 24320423
[TBL] [Abstract][Full Text] [Related]
12. Quantitative evaluation of 3D dosimetry for stereotactic volumetric-modulated arc delivery using COMPASS.
Vikraman S; Manigandan D; Karrthick KP; Sambasivaselli R; Senniandavar V; Ramu M; Rajesh T; Lutz M; Muthukumaran M; Karthikeyan N; Tejinder K
J Appl Clin Med Phys; 2014 Jan; 16(1):5128. PubMed ID: 25679152
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric validation and clinical implementation of two 3D dose verification systems for quality assurance in volumetric-modulated arc therapy techniques.
Clemente-Gutiérrez F; Pérez-Vara C
J Appl Clin Med Phys; 2015 Mar; 16(2):5190. PubMed ID: 26103189
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of one algorithm used to modify a planned DVH with data from actual dose delivery.
Ma T; Podgorsak MB; Kumaraswamy LK
J Appl Clin Med Phys; 2016 Sep; 17(5):273-282. PubMed ID: 27685140
[TBL] [Abstract][Full Text] [Related]
15. [Preliminary study on monitoring patient-specific volumetric modulated arc therapy quality assurance process with statistical process control methodology on the basis of TG-218 report].
Xiao Q; Li G; Li Z; Zhang X; Dai G; Bai S
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2020 Oct; 37(5):842-847. PubMed ID: 33140608
[TBL] [Abstract][Full Text] [Related]
16. Volumetric-modulated arc therapy: effective and efficient end-to-end patient-specific quality assurance.
O'Daniel J; Das S; Wu QJ; Yin FF
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1567-74. PubMed ID: 21470797
[TBL] [Abstract][Full Text] [Related]
17. Statistical analysis of correlation of gamma passing results for two quality assurance phantoms used for patient-specific quality assurance in volumetric modulated arc radiotherapy.
Kunii Y; Tanabe Y; Nakamoto A; Nishioka K
Med Dosim; 2022 Winter; 47(4):329-333. PubMed ID: 35850758
[TBL] [Abstract][Full Text] [Related]
18. Clinically relevant quality assurance (QA) for prostate RapidArc plans: gamma maps and DVH-based evaluation.
Cozzolino M; Oliviero C; Califano G; Clemente S; Pedicini P; Caivano R; Chiumento C; Fiorentino A; Fusco V
Phys Med; 2014 Jun; 30(4):462-72. PubMed ID: 24480527
[TBL] [Abstract][Full Text] [Related]
19. A study on the effect of detector resolution on gamma index passing rate for VMAT and IMRT QA.
Woon W; Ravindran PB; Ekayanake P; S V; Lim YY; Khalid J
J Appl Clin Med Phys; 2018 Mar; 19(2):230-248. PubMed ID: 29460465
[TBL] [Abstract][Full Text] [Related]
20. Texture analysis on the fluence map to evaluate the degree of modulation for volumetric modulated arc therapy.
Park SY; Kim IH; Ye SJ; Carlson J; Park JM
Med Phys; 2014 Nov; 41(11):111718. PubMed ID: 25370632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
